Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a

Guardian Pharmacy Services, Inc. (GRDN) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a P/E ratio of 37.8×. Over the past ten years it has ranged from 0.0× (September 2025) to 51.1× (June 2026); the current reading is higher than 32% of that period. That is above the Medical Care Facilities industry median of 17.4× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 38.1× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 38.8× (2.60%)
Jun 2026 39.9× (10.00%)
Mar 2026 44.3× 16.32%
Dec 2025 38.1× (5.61%)
8 more quarters

Against its own ten years

Low 0.0× High 51.1×
Ten-year median 39.9×
Current reading's percentile 32

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on GRDN